FRAMINGHAM (10/23/2003) - BioTrove Inc. has put its second integrated platform release, Momentum, to work in a patented ultra-high-throughput mass spectrometry service enabling microliter-scale functional assay development and screening of intractable targets. Through the Momentum Screening Service, BioTrove collaborates with customers to develop label-free assays and to screen chemical libraries against biological targets.
Momentum features a maximum sustainable throughput of one sample per second. With Momentum, an assay can be developed and validated for a novel target and screened against a small-molecule library in less than one month, BioTrove says.
Product Name: Momentum
For more information: www.biotrove.com